These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30688105)

  • 21. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients.
    Cappellari M; Cavallaro T; Ferrarini M; Cabrini I; Taioli F; Ferrari S; Merlini G; Obici L; Briani C; Fabrizi GM
    J Peripher Nerv Syst; 2011 Jun; 16(2):119-29. PubMed ID: 21692911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Waddington-Cruz M; Ando Y; Amass L; Kiszko J; Chapman D; Sekijima Y;
    J Peripher Nerv Syst; 2021 Jun; 26(2):160-166. PubMed ID: 33844361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy.
    Cortese A; Vegezzi E; Lozza A; Alfonsi E; Montini A; Moglia A; Merlini G; Obici L
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):457-458. PubMed ID: 28188196
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
    Fortanier E; Delmont E; Verschueren A; Attarian S
    Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination.
    Fargeot G; Viala K; Theaudin M; Labeyrie MA; Costa R; Léger JM; Adams D; Vandendries C; Labeyrie C
    Eur J Neurol; 2019 Apr; 26(4):631-638. PubMed ID: 30431216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP.
    Spina E; Doneddu PE; Liberatore G; Cocito D; Fazio R; Briani C; Filosto M; Benedetti L; Antonini G; Cosentino G; Jann S; Mazzeo A; Cortese A; Marfia GA; Clerici AM; Siciliano G; Carpo M; Luigetti M; Lauria G; Rosso T; Cavaletti G; Peci E; Tronci S; Ruiz M; Piccinelli SC; Schenone A; Leonardi L; Gentile L; Piccolo L; Mataluni G; Santoro L; Nobile-Orazio E; Manganelli F;
    J Neurol; 2022 Feb; 269(2):907-912. PubMed ID: 34173874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy.
    Doneddu PE; De Lorenzo A; Manganelli F; Cocito D; Fazio R; Briani C; Mazzeo A; Filosto M; Cosentino G; Benedetti L; Schenone A; Marfia GA; Antonini G; Matà S; Luigetti M; Liberatore G; Spina E; Peci E; Strano C; Cacciavillani M; Gentile L; Cotti Piccinelli S; Cortese A; Bianchi E; Nobile-Orazio E
    J Neurol Neurosurg Psychiatry; 2022 Dec; 93(12):1239-1246. PubMed ID: 36190959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
    Leonardi L; Vanoli F; Fionda L; Loreti S; Garibaldi M; Morino S; Salvetti M; Russo D; Musumeci B; Antonini G
    Neurol Sci; 2020 Dec; 41(12):3775-3778. PubMed ID: 32936357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy.
    Stanton M; Pannoni V; Lewis RA; Logigian EL; Naguib D; Shy ME; Cleland J; Herrmann DN
    Muscle Nerve; 2006 Oct; 34(4):417-22. PubMed ID: 16823858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies.
    Isose S; Kuwabara S; Kokubun N; Sato Y; Mori M; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Sawai S; Kanai K; Hirata K; Misawa S;
    J Peripher Nerv Syst; 2009 Sep; 14(3):151-8. PubMed ID: 19909478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
    Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of electrophysiological findings between CIDP and HMSN-1].
    Hasegawa O; Matsumoto S; Iino M; Kurita R; Kubota Y
    No To Shinkei; 1999 May; 51(5):411-4. PubMed ID: 10396746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
    Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S
    Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nerve conduction abnormalities in chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Baba M
    Rinsho Shinkeigaku; 1991 Dec; 31(12):1333-6. PubMed ID: 1817802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP.
    Cui RT; Huang XS; Liu JX; Chen ZH; Pu CQ
    J Clin Neurophysiol; 2012 Aug; 29(4):345-8. PubMed ID: 22854769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.